相关实验视频
Updated: Sep 19, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.7K
一个p53-准小分子的机械洞察力
Ricardo J F Ferreira1, Valentina Barcherini1, Catarina Roma-Rodrigues2,3,4
1Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa 1649-003, Portugal.
ACS pharmacology & translational science
|June 19, 2025
概括
一种新型化合物RVJB59有效地重新激活了癌细胞中的p53通路. 它在临床前模型中表现出低清除率,选择性结合p53和抗癌作用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 恢复野生型 (wt) 或突变型 (mut) p53是癌症治疗的关键策略.
- 托醇衍生氧化胺胺基基架已经产生了有前途的p53活性化剂.
- RVJB59是一种强效的 (R) - 三聚醇衍生氧化,具有较强的活性和选择性,比SLMP53-1.
研究的目的:
- 调查RVJB59.5的药理动力学特征和作用机制.
- 评估RVJB59及其代谢物的抗增殖活性.
- 评估RVJB59与p53的相互作用及其体内疗效.
主要方法:
- 在体外代谢降解研究中,使用人类肝脏显微体和大鼠肝脏S9分量 (LC/HRMS/MS).
- 与HCT116细胞对抗RVJB59代谢物的合成和抗增殖性评估.
- 差分扫描热量计 (DSF) 研究p53的热稳定性.
- 使用谷氨和重量p53 (HRMS/MS) 的共价结合试验.
- 在体外3D球形和体内胚胎模型.
主要成果:
- RVJB59在体外清除率低,其主要代谢物显示抗增殖活性降低.
- RVJB59增强了重量和R273H p53DNA结合域的热稳定性,通过选择性结合重量p53.5的Cys141.
- RVJB59减少了3D瘤球状体的生长,并在体内表现出抗血管性潜力.
结论:
- RVJB59是一种低清除化合物,具有有利的药理动力学特征.
- RVJB59选择性地准和稳定p53,从而产生抗癌效应.
- RVJB59显示出作为癌症治疗的p53-激活治疗剂的显著潜力.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Covalently Linked Protein Regulators
7.4K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.4K
Negative Regulator Molecules
36.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K

